Recurrent pleural effusion as a rare manifestation after prolonged PD1 inhibitor (camrelizumab)-based immunotherapy: A case report

• Main Authors: Xiao-Hong Xie (Author), Pan-Xiao Shen (Author), Jian-Hui Wu (Author), Gui-Huan Qiu (Author), Xin-Qing Lin (Author), Zhan-Hong Xie (Author), Yin-Yin Qin (Author), Bin Zheng (Author), Ming Liu (Author), Cheng-Zhi Zhou (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Immune-related adverse events (irAEs) pose a significant challenge for the widespread adoption of immuno-oncology therapies, but their symptoms can vary widely. In particular, the relationship between irAEs and pleural effusion (PE) in patients with advanced non-small cell lung cancer (NSCLC) remain...